Therapeutic application of nanotechnology in cardiovascular and pulmonary regeneration

Computational and Structural Biotechnology Journal

Volumn 7, Issue 8, 2013, Pages e201304005-

  Chun, Young Wook ^a   Crowder, Spencer W ^a   Mehl, Steven C ^a   Wang, Xintong ^a   Bae, Hojae ^b   Sung, Hak Joon ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896472964     PISSN: None     EISSN: 20010370     Source Type: Journal    
DOI: 10.5936/csbj.201304005     Document Type: Short Survey

References (53)

1. Chun Y, Webster, TJ. The role of nanomedicine ingrowing tissues. Annals of Biomedical Engineering. 2009;37:14.
2. Bichara DA O S N, Pomerantseva I, Zhao X, Sundback CA, Vacanti JP, Randolph MA. The tissue-engineered auricle:past, present, and future. Tissue engineering, Part B, Reviews. 2012;18:11.
3. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-6. (Pubitemid 23209960)
4. Dvir T TB, Kohane DS, Langer R. Nanotechnological strategies for engineering complex tissues, nature Nanotechnology. 2011;6:10.
5. Woo KM CV, Ma PX. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. Journal of biomedical materials research, Part A. 2003;67:7.
6. Ott HC, Matthiesen TS, Goh S-K, Black LD, Kren SM, Netoff TI, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008;14:213-21. (Pubitemid 351214548)
7. Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010;16:814-20.
8. Grayson WL, Frohlich M, Yeager K, Bhumiratana S, Chan ME, Cannizzaro C, et al. Engineering anatomically shaped human bone grafts. Proceedings of the National Academy of Sciences. 2009.
9. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MB, et al. Tissue-Engineered Lungs for in Vivo Implantation. Science. 2010;329:538-41.
10. Gui L, Muto A, Chan SA, Breuer CK, Niklason LE. Development of decellularized human umbilical arteries as small-diameter vascular grafts. Tissue engineering Part A. 2009;15:2665-76.
11. Fleischer S, Dvir T. Tissue engineering on the nanoscale: lessons from the heart. Curr Opin Biotechnol. 2012.
12. Erickson JP CN, McDonagh J. Fibronectin molecule visualized in electron microscopy: a long, thin, flexible strand. The Journal of cell biology. 1981;91:6.
13. Chan V, Raman R, Cvetkovic C, Bashir R. Enabling microscale and nanoscale approaches for bioengineered cardiac tissue. ACS Nano. 2013;7:1830-7.
14. Ravichandran R, Seitz V, Reddy Venugopal J, Sridhar R, Sundarrajan S, Mukherjee S, et al. Mimicking native extracellular matrix with phytic Acid-crosslinked protein nanofibers for cardiac tissue engineering. Macromol Biosci. 2013;13:366-75.
15. Stout DA, Yoo J, Santiago-Miranda AN, Webster TJ. Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. Int J Nanomedicine. 2012;7:5653-69.
16. RO H. The extracellular matrix: Not just pretty fibrils. Science. 2009;326:4.
17. Ayres CE, Jha BS, Sell SA, Bowlin GL, Simpson DG. Nanotechnology in the design of soft tissue scaffolds: innovations in structure and function. Wiley interdisciplinary reviews Nanomedicine and nanobiotechnology. 2010;2:20-34.
18. Barnes CP, Sell SA, Boland ED, Simpson DG, Bowlin GL. Nanofiber technology: designing the next generation of tissue engineering scaffolds. Advanced drug delivery reviews. 2007;59:1413-33. (Pubitemid 350122771)
19. Bettinger CJ, Langer R, Borenstein JT. Engineering substrate topography at the micro- and nanoscale to control cell function. Angewandte Chemie (International ed in English). 2009;48:5406-15.
20. Khang D, Carpenter J, Chun Y, Pareta R, Webster T. Nanotechnology for regenerative medicine. Biomed Microdevices. 2010;12:575-87.
21. Chun YW, Lim H, Webster TJ, Haberstroh KM. Nanostructured bladder tissue replacements. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2011;3:134-45.
22. Teixeira Al, Abrams GA, Berries PJ, Murphy CJ, Nealey PF. Epithelial contact guidance on well-defined micro- and nanostructured substrates. Journal of Cell Science. 2003;116:1881-92. (Pubitemid 36622287)
23. Sy JC, Seshadri G, Yang SC, Brown M, Oh T, Dikalov S, et al. Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. Nature materials. 2008;7:863-8.
24. Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. The Journal of clinical investigation. 2006;116:237-48. (Pubitemid 43121809)
25. Ruvinov E, Leor J, Cohen S. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model. Biomaterials. 2010;31:4573-82.
26. Ruvinov E, Leor J, Cohen S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials. 2011;32:565-78.
27. Garbern JC, Minami E, Stayton PS, Murry CE. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 2011;32:2407-16.
28. Dvir T, Kedem A, Ruvinov E, Levy O, Freeman I, Landa N, et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:14990-5.
29. Fitzpatrick JR, 3rd, Frederick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, et al. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction. The Journal of thoracic and cardiovascular surgery. 2010;140:667-76.
30. Miyagi Y, Zeng F, Huang XP, Foltz WD, Wu J, Mihic A, et al. Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. Biomaterials. 2010;31:7684-94.
31. Parker KK, Ingber DE. Extracellular matrix, mechanotransduction and structural hierarchies in heart tissue engineering. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2007;362:1267-79. (Pubitemid 47195021)
32. Lovett M LK, Edwards A, Kaplan DL. Vascularization strategies for tissue engineering. Tissue engineering, Part B, Reviews. 2009;15:18.
33. Rouwkema J RN, van Blitterswijk C. Vascularization in tissue engineering. Trends in biotechnology. 2008;26:8.
34. Tzvetkova-Chevolleau T SA, Fuard D, Ohayon J, Schiavone P, Tracqui P. The motility of normal and cancer cells in response to the combined influence of the substrate rigidity and anisotropic microstructure. Biomaterials. 2008;29:11.
35. Xu CY IR, Kotaki M, Ramakrshna S. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. Biomaterials. 2004;25:10.
36. Zhang L CY, Webster TJ. Decreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapies. Int J Nanomedicine. 2010;5:7.
37. Zorlutuna P VP, Hasirci V. Both sides nanopatterned tubular collagen scaffolds as tissue-engeered vascular grafts. Journal of tissue engineering and regenerative medicine. 2010;4:10.
38. Webber MJ, Tongers J, Newcomb CJ, Marquardt KT, Bauersachs J, Losordo DW, et al. Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:13438-43.
39. Akbarzadeh A SM, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. Journal of nanobiotechnology. 2012;10:13.
40. Stout DA YJ, Santiago-Miranda A, Noemi SA, Webster TJ. Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. Int J Nanomedicine. 2012;7:17.
41. Krishnan A, Dujardin E, Ebbesen TW, Yianilos PN, Treacy M M J. Young's modulus of single-walled nanotubes. Physical Review B. 1998;58:14013-9. (Pubitemid 128480434)
42. Polizu S, Savadogo O, Poulin P, Yahia L. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology. Journal of nanoscience and nanotechnology. 2006;6:1883-904. (Pubitemid 44599074)
43. Menard-Moyon C, Kostarelos K, Prato M, Bianco A. Functionalized carbon nanotubes for probing and modulating molecular functions. Chemistry & biology. 2010;17:107-15.
44. Singh R Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. Journal of the American Chemical Society. 2005;127:4388-96. (Pubitemid 40463064)
45. Gilmore JL, Yi X, Quan L, Kabanov AV. Novel nanomaterials for clinical neuroscience. Journal of neuroimmune pharmacology: the official journal of the Society on Neuroimmune Pharmacology. 2008;3:83-94.
46. Martinelli V CG, Toma FM, Log CS, Caldwell JH, Zentilin L, Giacca M, Turco A, Prato M, Ballerini L, Mestroni L. Carbon nanotubes promote growth and spontaneous electrical activity in cultured cardiac myo cytes. Nano letters. 2012;12:8.
47. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation. 2000;102:Iii56-61.
48. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006;12:452-8.
49. Bursac N, Loo Y, Leong K, Tung L. Novel anisotropic engineered cardiac tissues: studies of electrical propagation. Biochemical and biophysical research communications. 2007;361:847-53. (Pubitemid 47259017)
50. Dvir T, Timko BP, Brigham MD, Naik SR, Karajanagi SS, Levy O, et al. Nanowired three-dimensional cardiac patches. Nat Nano. 2011;6:720-5.
51. Dvir T, Bauer M, Schroeder A, Tsui JH, Anderson DG, Langer R, et al. Nanoparticles Targeting the Infarcted Heart. Nano Letters. 2011;11:4411-4.
52. Weis SM. Vascular permeability in cardiovascular disease and cancer. Current opinion in hematology. 2008;15:243-9. (Pubitemid 351509347)
53. Molavi B, Chen J, Mehta JL. Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. American journal of physiology Heart and circulatory physiology. 2006;291:H687-93. (Pubitemid 44175074)